These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 26242894)

  • 41. Genetics and the etiology of childhood cancer.
    Knudson AG
    Pediatr Res; 1976 May; 10(5):513-7. PubMed ID: 180483
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cancer and genes: how will molecular biology reshape our clinical practice?
    Ponder BA
    Neth J Med; 1997 May; 50(5):211-5. PubMed ID: 9175402
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stem cell replication, somatic mutations and role of randomness in the development of cancer.
    Perduca V; Alexandrov LB; Kelly-Irving M; Delpierre C; Omichessan H; Little MP; Vineis P; Severi G
    Eur J Epidemiol; 2019 May; 34(5):439-445. PubMed ID: 30623292
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antimutagens, anticarcinogens, and effective worldwide cancer prevention.
    Weisburger JH
    J Environ Pathol Toxicol Oncol; 1999; 18(2):85-93. PubMed ID: 15281219
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aneuploidy, the primary cause of the multilateral genomic instability of neoplastic and preneoplastic cells.
    Duesberg P; Fabarius A; Hehlmann R
    IUBMB Life; 2004 Feb; 56(2):65-81. PubMed ID: 15085930
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.
    Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J
    Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk factors for cancer.
    Lyman GH
    Prim Care; 1992 Sep; 19(3):465-79. PubMed ID: 1410059
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stem cells, melanoma and cancer stem cells: the good, the bad and the evil?
    Menaa F; Houben R; Eyrich M; Broecker EB; Becker JC; Wischhusen J
    G Ital Dermatol Venereol; 2009 Jun; 144(3):287-96. PubMed ID: 19088701
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification and chemoprevention in subjects at moderate risk of colorectal cancer.
    Benamouzig R; Uzzan B
    Best Pract Res Clin Gastroenterol; 2011 Aug; 25(4-5):631-40. PubMed ID: 22122777
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bad luck, no luck, good luck!
    Michalek AM
    J Cancer Educ; 2015 Jun; 30(2):205-6. PubMed ID: 25820532
    [No Abstract]   [Full Text] [Related]  

  • 51. Primary prevention of colorectal cancer: myth or reality?
    Crosara Teixeira M; Braghiroli MI; Sabbaga J; Hoff PM
    World J Gastroenterol; 2014 Nov; 20(41):15060-9. PubMed ID: 25386054
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oncogenic somatic events in tissue-specific stem cells: a role in cancer recurrence?
    Hartwig FP; Nedel F; Collares T; Tarquinio SB; Nör JE; Demarco FF
    Ageing Res Rev; 2014 Jan; 13():100-6. PubMed ID: 24374269
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Peto's paradox and human cancers.
    Noble R; Kaltz O; Hochberg ME
    Philos Trans R Soc Lond B Biol Sci; 2015 Jul; 370(1673):. PubMed ID: 26056357
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pomegranate derived products for cancer chemoprevention.
    Syed DN; Afaq F; Mukhtar H
    Semin Cancer Biol; 2007 Oct; 17(5):377-85. PubMed ID: 17613245
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chemoprevention of prostate cancer.
    Brand TC; Canby-Hagino ED; Pratap Kumar A; Ghosh R; Leach RJ; Thompson IM
    Hematol Oncol Clin North Am; 2006 Aug; 20(4):831-43. PubMed ID: 16861117
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Paradoxes in carcinogenesis: new opportunities for research directions.
    Baker SG; Kramer BS
    BMC Cancer; 2007 Aug; 7():151. PubMed ID: 17683619
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cohorts with familial disposition for colon cancers in chemoprevention trials.
    Burt RW
    J Cell Biochem Suppl; 1996; 25():131-5. PubMed ID: 9027609
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical management of patients at inherited risk for gynecologic cancer.
    Powell CB
    Curr Opin Obstet Gynecol; 2015 Feb; 27(1):14-22. PubMed ID: 25490378
    [TBL] [Abstract][Full Text] [Related]  

  • 59. p53 family members in cancer diagnosis and treatment.
    Machado-Silva A; Perrier S; Bourdon JC
    Semin Cancer Biol; 2010 Feb; 20(1):57-62. PubMed ID: 20206267
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions.
    Tomasetti C; Vogelstein B
    Science; 2015 Jan; 347(6217):78-81. PubMed ID: 25554788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.